Abstract:External-beam radiation therapy mostly uses high-energy photons (x-rays) produced by medical accelerators, but many facilities now use proton beams, and a few use fast-neutron beams. High-energy photons offer several advantages over lower-energy photons in terms of better dose distributions for deep-seated tumors, lower skin dose, less sensitivity to tissue heterogeneities, etc. However, for beams operating at or above 10 MV, some of the materials in the accelerator room and the radiotherapy patient become radioactive due primarily to photonuclear reactions and neutron capture, exposing therapy staff and patients to unwanted radiation dose. Some recent advances in radiotherapy technology require treatments using a higher number of monitor units and monitor-unit rates for the same delivered dose, and compared to the conventional treatment techniques and fractionation schemes, the activation dose to personnel can be substantially higher. Radiotherapy treatments with proton and neutron beams all result in activated materials in the treatment room. In this report, the authors review critically the published literature on radiation exposures from induced radioactivity in radiotherapy. They conclude that the additional exposure to the patient due to induced radioactivity is negligible compared to the overall radiation exposure as a part of the treatment. The additional exposure to the staff due to induced activity from photon beams is small at an estimated level of about 1 to 2 mSv y(-1). This is well below the allowed occupational exposure limits. Therefore, the potential hazard to staff from induced radioactivity in the use of high-energy x-rays is considered to be low, and no specific actions are considered necessary or mandatory. However, in the spirit of the "As Low as Reasonably Achievable (ALARA)" program, some reasonable steps are recommended that can be taken to reduce this small exposure to an even lower level. The dose reduction strategies suggested should be followed only if these actions are considered reasonable and practical in the individual clinics. Therapists working with proton beam and neutron beam units handle treatment devices that do become radioactive, and they should wear extremity monitors and make handling apertures and boluses their last task upon entering the room following treatment. Personnel doses from neutron-beam units can approach regulatory limits depending on the number of patients and beams, and strategies to reduce doses should be followed.

Study on Induced Radioactivity in Proton Therapy Accelerators

SU‐FF‐T‐452: the Manageable Levels of Induced Radioactivity in Medical Accelerators from High Energy Photon Beams

Evaluating activation of the shielding walls of a treatment room using the Monte Carlo method

Monte Carlo Calculation of Induced Radioactivity for a 15-MV Electron Accelerator Head Structure

Simulation of Induced Radioactivity for A Heavy Ion Medical Machine

Potential Hazard Due to Induced Radioactivity Secondary to Radiotherapy: the Report of Task Group 136 of the American Association of Physicists in Medicine

Simulation of induced radioactivity for Heavy Ion Medical Machine

Radiation transport calculations for the European Spallation Source accelerator environment

STUDY ON THE SHIELDING AND DOSE RATE DISTRIBUTIONS OF THERAPEUTIC PROTON SYNCHROTRON ACCELERATOR BASED ON FLUKA

The Problems of Environmental Safety for Applicationof High Energy Proton Accelerator Therapy System

An investigation of neutron shielding and activation performances of four types of concrete for carbon ion therapy facility

On the neutron radiation field and air activation around a medical electron linac

Assessment of the induced radioactivity in the treatment room of the heavy-ion medical machine in Wuwei using PHITS

Human radiological safety assessment for petawatt laser-driven ion acceleration experiments in CLAPA-T

A torus source and its application for non-primary radiation evaluation

Dose Measurements at Provision Proton Therapy Center

MCNP simulation of X-ray beam for a 15 MV medical linear accelerator

Assessment of radio-activation using spectroscopy in medical linear accelerators

Neutron dose distribution in treatment room for an accelerator with flattening filter free

Research on the Induced Radioactivity of HTR-PM’s Reactor Pressure Vessel: A Comparative Study Between FLUKA, KORIGEN and QAD-CGA

Neutron dose distribution in the treatment room for an accelerator in the flattening filter-free mode